No Data
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer
Raymond James Downgrades Omega Therapeutics(OMGA.US) to Hold Rating
Raymond James Downgrades Omega Therapeutics to Market Perform From Outperform
Piper Sandler Maintains Omega Therapeutics(OMGA.US) With Buy Rating, Cuts Target Price to $4
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
Express News | Omega Therapeutics Inc : Piper Sandler Cuts Target Price to $4 From $9
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
